Triple Negative Cancer

This volume summarizes the treatment options from the onset of breast carcinogenesis to early-local advanced and metastatic breast cancer. This book includes a comparison between different chemotherapy agents and targeted therapies with published phase II-III studies. Photodynamic treatments have been included in this book.

This book discusses various aspects of breast cancer carcinogenesis from clinics to its hormone-based as well as genetic-based etiologies for this deadly cancer. The book will contribute to the development of novel diagnostic as well as therapeutic approaches.

This book consolidates recent advances in breast cancer biology and therapeutics, covering a broad spectrum of interrelated subjects. The book covers topics such as pathobiology of breast cancer, biomarkers, in vitro models of breast cancer, pharmacotherapy, screening and management, diagnostic imaging, and more.

This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters.

This text is designed to present a comprehensive and state-of the-art approach to the management of breast cancer within the fields of surgery, medical oncology, and radiation oncology. Sections address changes in these fields. These areas include breast imaging, management of the axilla, atypical breast lesions, surgical margins, new techniques in breast reconstruction, and nipple sparing and contralateral mastectomies.